CIK 0001626878
- Non-accelerated filer
- Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- Open-market buys, last 90 days
- $854,660
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$854,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-06 | MCKENZIE W THORPE Director | Option exercise · Stock Option | −46,000 | 1,199,500 | ||
| 2019-12-06 | SIMARD JOHN Chief Executive Officer | Option exercise · Stock Option | +1,000,000 | $11.12 | $11.1M | 2,625,000 |
| 2019-11-29 | MCKENZIE W THORPE Director | Option exercise | +185,000 | $3.75 | $694K | 3,583,600 |
| 2019-11-29 | MCKENZIE W THORPE Director | Option exercise · Stock Option | −185,000 | 0 | ||
| 2019-11-06 | HAN QUEENA VP Finance & HR | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2019-11-06 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise · Stock Option | +100,000 | 100,000 | ||
| 2019-09-06 | MCKENZIE W THORPE Director | Sale | −7,159 | $3.69 | $26K | 3,880,421 |
| 2019-07-10 | Libby Peter Director | Grant or award · Director Stock option | +25,000 | 25,000 | ||
| 2019-06-27 | Waldin Jan-Paul Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2019-06-27 | MCKENZIE W THORPE Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2019-06-27 | MacAdam Donald H. Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2019-06-27 | SIMARD JOHN Chief Executive Officer | Option exercise · Stock Option | +300,000 | $7.45 | $2.2M | 300,000 |
| 2019-06-04 | RENNES FONDATION 10% owner | Purchase | +1,200,000 | $8.25 | $9.9M | 5,110,282 |
| 2019-03-07 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise · Stock options | −4,500 | 0 | ||
| 2019-03-04 | RENNES FONDATION 10% owner | Purchase | +16,426 | $7.91 | $130K | 3,910,282 |
| 2019-03-01 | RENNES FONDATION 10% owner | Purchase | +34,999 | $8.13 | $285K | 3,893,856 |
| 2019-02-28 | RENNES FONDATION 10% owner | Purchase | +5,302 | $8.19 | $43K | 3,858,857 |
| 2019-02-27 | RENNES FONDATION 10% owner | Purchase | +5,273 | $8.13 | $43K | 3,853,555 |
| 2019-02-07 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise | +4,500 | $2.50 | $11K | 4,500 |
| 2019-02-07 | SHIVASWAMY SUSHMA Chief Scientific Officer | Sale | −4,500 | $10.00 | $45K | 0 |
Page 7 of 14 · 273 trades